Research Reports

Every report we've published, newest first.

NIVF

NIVF Doubles Premarket Off Its $0.07 Offering Price — Anatomy of a Dilution-Cycle Bounce

Sep 30, 2026

NIVF is up triple digits premarket with no new headline — a structural bounce off the $0.07 offering price that just nine-folded the share count. Here's how the machine works and the levels that matter.

Read →
FRGT

FRGT Rips Pre-Market on Zero News — A Sub-600K Float Doing What Sub-600K Floats Do

Sep 30, 2026

Freight Technologies is up 35%+ pre-market with no news anywhere — just a float under 600K shares getting turned over dozens of times before the open. Here's the bracket that matters.

Read →
BKYI

BKYI Rips 40%+ Premarket on Gulf Partnership — But the Warrant Vote Friday Is the Real Story

Sep 29, 2026

BIO-key gapped over 40% premarket on a Gulf-region partnership announcement — but with a sub-1.5M float, a faded spike, and a 1.24M-share warrant vote set for Friday, the supply math deserves as much attention as the headline.

Read →
SLXN

SLXN Nearly Doubles Overnight on SIL204 Data — But the Regular Session Ignored the Same News for Six Hours

Sep 29, 2026

SLXN nearly doubled overnight on SIL204 preclinical data the regular session ignored for six hours — a momentum-discovery move on a share structure that's grown 6x in a quarter, with an ATM live and a fourth reverse split pending.

Read →
WBUY

WBUY: Grocery App Turned Travel Company Doubles Revenue, and the Float Can't Handle It

Sep 28, 2026

Webuy Global gapped hard premarket Monday after reporting H1 2026 revenue up 94% to $14.3M as its grocery-to-travel pivot completed — and a sub-3M float turned the news into a violent auction before the bell.

Read →
MEDS

MEDS Gaps 30% Pre-Market on GLP-1 App Launch — But the Convertible Note Machinery Sets the Ceiling

Sep 28, 2026

DataMeds AI delivered its promised GLP-1 app launch with NFL Alumni Health and the stock gapped ~30% pre-market on massive float rotation — but convertible notes that price off the prior close, plus 34M registered resale shares, define the ceiling.

Read →
INLF

INLF Nearly Doubles on a Real Earnings Print — But the Release Also Buried Another 1-for-200 Reverse Split

Sep 25, 2026

INLF's second run of the year finally has a real catalyst — a swing to profitability on 26% revenue growth — but the same release flagged another 1-for-200 reverse split, and the sub-1M float is doing most of the work.

Read →
APUS

APUS Doubled on a Blockchain Deal, Not Bee Venom — Anatomy of a Half-Million-Share Float Squeeze

Sep 25, 2026

Apimeds Pharmaceuticals doubled Thursday on a blockchain services deal from its MindWave subsidiary — not its bee-venom drug. With a float in the mid-500Ks rotating ~150 times, this is a textbook micro-float squeeze with a PIPE overhang worth watching.

Read →
GRML

GRML Gaps Up Premarket on a $42M Raise at $12 — Now $12 Is the Only Level That Matters

Sep 24, 2026

Greenland Mines priced a $42M registered direct at $12 — above Wednesday's close — killed its ATM, and gapped up premarket. The deal price is now the level the whole trade pivots on.

Read →
PFSA

PFSA Nearly Doubles Premarket on CE Mark Progress — But the Real Story Is a Float Measured in the Hundreds of Thousands

Sep 24, 2026

Profusa's ISO 13485 news is a real regulatory checkpoint — but a share count carved down by three reverse splits this year is what turned it into a near-100% premarket move.

Read →
BENF

BENF Quadruples Premarket as Beneficient Moves to Erase the Heppner Debt — Anatomy of a Sub-3M Float Repricing

Sep 23, 2026

Beneficient announced a strategy to wipe out its former CEO's fabricated debt and $850M in preferred claims — and a sub-3M float repriced 300%+ before the open. Here's how the mechanics work and the levels that matter.

Read →
DCOY

DCOY Runs Again Premarket as Warrant Inducement Shares Prepare to Land

Sep 23, 2026

Decoy Therapeutics is up big again premarket with no fresh headline — while a warrant inducement closing today prepares to nearly triple the share count at a $3.25 strike.

Read →
IMCC

IMCC's No-News Moonshot: A Sub-600K Float Doing Squeeze Math, Round Two Premarket

Sep 22, 2026

IMCC tripled Friday on zero news and is ripping again premarket. The catalyst isn't a headline — it's a sub-600K float after a 30-for-1 reverse split, and the mechanics tell you everything about how this trades from here.

Read →
GDC

GDC Pre-Market Surge: No News, Just a 4M-Share Float Doing Float Things

Sep 22, 2026

GDC is extending Monday's spike in pre-market on volume that already exceeds its post-split float — with no news, no filing, and an effective shelf sitting overhead. Pure mechanics.

Read →
NCPL

NCPL Runs Three Sessions With No News: A 4M-Share Float Doing the Heavy Lifting

Sep 21, 2026

NCPL stacked a third leg premarket Monday after Thursday-Friday's run — with no identified catalyst. A sub-5M float doing all the work, against a backdrop of an unfiled 10-K and SEC scrutiny.

Read →
LOBO

LOBO: Friday's Earnings Lit a Sub-10M Float — the Bracket Into Monday's Open

Sep 21, 2026

LOBO is gapping more than 30% premarket Monday after Friday's post-close H1 report showed revenue up 20.6% and a sharply narrowed loss — and a sub-10M float is doing the amplifying. Here's the bracket into the open.

Read →
GIPR

GIPR Doubles Premarket on Zero Fresh News: The Sub-3M Float Is Turning Over Every Few Hours — Again

Sep 18, 2026

GIPR doubled premarket Friday with no headline behind it — just a sub-3M post-split float turning over 15x a day for two straight sessions, warrants parked far overhead, and a $4.2M preferred redemption deadline on September 30.

Read →
SSM

SSM Rips Premarket on No New Headline — the Sports One Shell Trade Reloads Off All-Time Lows

Sep 18, 2026

SSM is up 50%+ premarket with no fresh news — a nano-float snapback off all-time lows, riding the non-binding Sports One reverse-merger story while a live shelf sits overhead.

Read →
CTNT

CTNT Nearly Doubles Premarket Off a Three-Day 96% Wipeout — The $35M ATM Is the Whole Story

Sep 17, 2026

Cheetah Net is nearly doubling premarket with no fresh catalyst — a structural bounce off a $35M ATM-driven collapse that erased 96% in three sessions. One 8-K flips this from dead cat to squeeze.

Read →
DTSS

DTSS Premarket Rip Is the Second Act of a Pop That Already Failed Once — Watch $0.80

Sep 17, 2026

DTSS is up big premarket Thursday with no fresh news — the second act of Wednesday's AI elderly-care robot pop that spiked to $0.80 and got sold to a new low. A freshly effective F-3 shelf sits overhead.

Read →
RETO

RETO's 676% Day Had No News Behind It — Here's the Float Math That Made It Possible

Sep 16, 2026

ReTo Eco-Solutions ran 676% Tuesday with no catalyst attached — a pure low-float momentum move built on a May reverse split, with a $36M prepaid financing waiting overhead. Here are the day-two levels.

Read →
TPST

TPST Rips Premarket on Senlang CAR-T Option Deal — Float Already Rotated Once Before the Bell

Sep 16, 2026

Tempest Therapeutics announced an exclusive option to license Senlang's clinical-stage CD7-targeted CAR-T platform after Tuesday's close, sending the sub-10M float name up more than 40% premarket — with the entire float already rotating before the bell.

Read →
MYSZ

MYSZ Gaps 45% Premarket on Defense-Tech Pivot — A Sub-700K Float Does the Rest

Sep 15, 2026

MySize announced a pivot from fashion-sizing tech to defense acquisitions with no target named — and a float under 700K shares did the rest, gapping the stock 45% premarket on volume that turned the float over twentyfold.

Read →
VEEA

VEEA Gaps 80% Pre-Market on NovaGen Merger Term Sheet — A Levels Guide to a 1.59M-Share Float

Sep 15, 2026

VEEA is gapping 80%+ pre-market after signing a merger term sheet with longevity firm NovaGen, backed by a $10M GeoNova commitment — and a post-split float under 2M shares is doing the amplifying.

Read →
SCNI

SCNI Gaps 45% Pre-Market on a Sub-700K Float — No News, All Mechanics

Sep 14, 2026

Scinai Immunotherapeutics is gapping ~45% pre-market with no news behind it — just a sub-700K post-split float meeting twenty times its own size in volume before the bell.

Read →
NCT

NCT Rips Premarket on No News — Intercont's Tiny Float Is the Whole Story, and a $200M Shelf Is Sitting Effective

Sep 14, 2026

Intercont (NCT) is up ~70% premarket on no news, with volume running multiples of its sub-9M float — two weeks after a 93% collapse and four days after its $200M shelf went effective.

Read →
TNON

TNON Premarket Squeeze: Note Repayment Killed a Death-Spiral Overhang Two Days Before It Activated

Sep 10, 2026

TNON is squeezing premarket after repaying $5.16M in convertible notes 48 hours before their discounted-conversion window opened — but a fresh resale registration covers nearly 3x the share count.

Read →
SLXN

SLXN: Silexion's Premarket Pop Is a Mechanics Story, Not a Medicine Story

Sep 10, 2026

Silexion Therapeutics gapped double digits premarket on volume that turned its sub-6M float many times over — with nothing behind it but a conference calendar. The reverse-split delisting clock and August dilution machinery are the real story.

Read →
ISPC

ISPC Gaps 23% on Foldlab AI Deal — a 2.5M-Share Float Meets a Proxy Full of Fine Print

Sep 8, 2026

iSpecimen's Friday-night deal to buy Foldlab's AI disease-analytics assets lit up a 2.5M-share float into Tuesday's premarket — but the same day's proxy filing asks for another reverse split and convertibles at up to an 80% discount.

Read →
GMEX

GMEX Doubles Premarket Then Fades — No News, Just a Sub-1M Share Count Doing Sub-1M Share Count Things

Sep 8, 2026

GMEX nearly doubled premarket on volume many multiples of its entire share count — with zero overnight news. The move is structural: a sub-1M share count, two reverse splits in two months, and a rollout date bulls may be front-running.

Read →
OFAL

OFAL Gaps Up Pre-Market on QikBIM "Viral" PR — A 1.86M Float Meets a Social-Media Catalyst

Sep 4, 2026

OFAL is gapping pre-market on a QikBIM "viral 90 days" press release claiming first subscription revenue — but the real engine is a sub-2M post-split float with a documented history of sold spikes.

Read →
GIPR

GIPR Gaps 50%+ Premarket on Zero News: Sub-3M Float Squeeze With a Nasdaq Panel Decision Hanging Over It

Sep 3, 2026

GIPR is up more than 50% premarket on enormous volume with no overnight news — a sub-3M float doing the heavy lifting while a Nasdaq hearings panel decision on the $1.00 bid-price deficiency hangs over the tape.

Read →
GELS

GELS Runs Again on No News: Anatomy of a Low-Float Re-Run in Gelteq

Sep 3, 2026

Gelteq spiked September 2 on volume seven times its share count with zero news behind it, and the premarket tape is extending. Here's the low-float mechanics lesson — and the convertible note supply that could meet the move.

Read →
BIAF

BIAF Premarket Rip: A 573K-Share Float Meets 10 Million Shares of Volume — No News Required

Sep 1, 2026

BIAF is ripping premarket with no news behind it — just a post-reverse-split float under 600K shares meeting massive volume. The August S-3 and a $4M placement struck near $7.09 split-adjusted define the supply zone above.

Read →
COOT

COOT Gaps Premarket With No Headline — and the Company Sold Its Entire Business for $1 in July

Aug 31, 2026

COOT ripped premarket Monday with no news — weeks after selling its entire operating business to a Singapore buyer for one US dollar. Here's what the tape, the filings, and the $0.46–$0.74 bracket say.

Read →
WHLR

WHLR Rips 60%+ Premarket on No News — The Post-Split Bounce Inside a Running Dilution Machine

Aug 28, 2026

WHLR spiked more than 60% premarket Friday with zero news behind it — a structural bounce off Thursday's post-split flush, inside a capital structure that prints new common shares every month.

Read →
AEMD

AEMD Rips Pre-Market on No News — A Sub-700K Float Doing Sub-700K Float Things

Aug 28, 2026

AEMD is ripping pre-market with zero news behind it — just a sub-700K float, two reverse splits in ten months, and volume that's rotated the float many times over before the open.

Read →
WNW

WNW Gaps 30% Premarket on $35M Acquisition Filing — and the Fine Print Raises a Financing Question

Aug 27, 2026

Meiwu Technology gapped roughly 30% premarket after a 6-K disclosed a ~$35M cash deal for Xiamen Hemeitong — but March's zero-exercise warrants can mint up to 12 shares apiece, and the early tape is already fading off its highs.

Read →
WKSP

WKSP's Premarket Round Trip: Five Float Turns Before the Bell on Day-Old News

Aug 27, 2026

Worksport turned its float over roughly five times before Thursday's open, spiking to $0.85 and fading — on news the market ignored a day earlier. The mechanics, the shelf overhead, and the levels that matter now.

Read →
ELPW

ELPW Rips Premarket on Zero News — the 1-for-45 Split Just Shrank the Share Count to Almost Nothing

Aug 11, 2026

ELPW is spiking premarket with no news attached — Monday's 1-for-45 reverse split shrank the share count to roughly half a million shares, and the tape is repricing the new supply picture in real time.

Read →
MTEN

MTEN Premarket Follow-Through: Reading the Tape on a Sub-7M Float With a Fresh Resale Shelf Overhead

Aug 11, 2026

MTEN turned its float over several times Monday on zero news and is up another ~20% premarket. The real story is the structure: a fresh resale registration just went effective and warrant sellers wait at $2.00.

Read →
XHLD

XHLD Gaps Up Again Pre-Market — Thursday's Squeeze Has a Second Act, and a Freshly Effective S-3 Behind It

Aug 10, 2026

TEN Holdings is gapping up again Monday pre-market with no news behind it — a second act to Thursday's 252% float squeeze, running straight into a freshly effective S-3 shelf and earnings due August 13.

Read →
AUUD

AUUD Doubles Premarket as SEC Clears Merger S-4 — The Skeptic's Read on the McCarthy Finney Handoff

Aug 10, 2026

Auddia caught a real catalyst — SEC effectiveness of the S-4 for its merger with Thramann Holdings — and nearly doubled premarket on a sub-5M float. The Skeptic walks through the related-party structure and the levels that decide the open.

Read →
CELZ

CELZ Rips Premarket on Patent Headline — But Wednesday's Tape Moved First, and the Shelf Is Freshly Loaded

Aug 6, 2026

CELZ traded huge volume Wednesday and closed flat — then a patent headline hit after hours and a sub-5M float did the rest. The freshly effective shelf is the risk nobody's pricing.

Read →
ENSC

ENSC Rockets Premarket on Cy Biopharma Acquisition — Here's How the $77M Financing Actually Works

Aug 6, 2026

Ensysce spiked in Wednesday premarket after announcing the completed acquisition of Cy Biopharma and up to $77M in private financing — a deal several times its market cap. Here's how the three-bucket financing actually works and where the new shares come from.

Read →
YXT

YXT Triples Premarket on No New Headline — a Sub-5M Float Doing Float-Squeeze Math

Aug 5, 2026

YXT roughly tripled in Wednesday premarket trade with no fresh headline — just a sub-5M float meeting millions of shares of demand after a 1-for-10 ADS ratio change and a live $100M shelf.

Read →
BJDX

BJDX Premarket Squeeze: A Sub-Million Float Meets 20M Shares of Volume — No News Required

Aug 5, 2026

BJDX is up roughly 39% in Tuesday's premarket with no fresh headline — a sub-million-share float meeting tens of millions of shares in volume. Here's how the mechanics work and where the supply is hiding.

Read →
TNMG

TNMG Nearly Doubles Premarket: Strategic-Alternatives Review Meets a Two-Million-Share Float

Aug 4, 2026

TNL Mediagene stacked a strategic-alternatives review, a Miro AI partnership, and a fully repaid convertible note onto a two-million-share float — and the premarket tape exploded.

Read →
ELPW

ELPW's Premarket Bounce Is the Offering Cycle Working in Reverse — Here's the Mechanism

Aug 4, 2026

ELPW is up ~60% in Tuesday's premarket with no new headline — it's the rebound leg of Monday's $0.12 unit offering flush. Here's how the dilution cycle works and the levels that define the trade.

Read →
MGRX

MGRX Doubles Premarket as the Market Changes Its Mind About the Nuclea Nuclear Reverse Merger

Jul 31, 2026

The same nuclear microreactor deal that cut MGRX in half on Thursday has it doubling premarket Friday. The 96% dilution math hasn't changed — but the near-term float mechanics explain the whiplash.

Read →
WETO

WETO Quadruples Premarket: $20M Robotics Deal, Qualcomm PR, and a 1-for-100 Split That Rounds Up

Jul 31, 2026

WETO nearly quadrupled premarket on a $20M warehouse robotics agreement, a Qualcomm Partner Network announcement, and round-up mechanics ahead of Monday's 1-for-100 share consolidation — with the float turning over roughly ten times before the bell.

Read →
GCTK

GCTK: Lōkahi's Minipig Data Sparks a 70% After-Hours Rip — But Read the Exchange Agreement First

Jul 30, 2026

GCTK surged over 70% after hours on real news — single-injection data for Lōkahi's LT-100 program — but a $900K note exchange, convertible paper, and a pending reverse-split vote define the supply side of this trade.

Read →
SXTC

SXTC Bounces Premarket on Zero News — Anatomy of the Offering That Broke the Stock

Jul 30, 2026

SXTC is ripping premarket on massive volume with zero news — a structural bounce off the wreckage of a $9M offering that vaporized 80% of the stock in one session. Here's the dilution machinery behind the crash and the levels that matter now.

Read →
AMIX

AMIX Gaps 60% Pre-Market: The Catalyst Was an 8-K Showing More Cash Per Share Than the Stock Price

Jul 29, 2026

Autonomix Medical closed Tuesday red at $2.75, then ripped 54% after hours — the catalyst wasn't a press release, it was an 8-K showing roughly $5.25 per share in cash. Now a sub-1M float has turned over a dozen times before the open, with $5.75 warrant supply waiting overhead.

Read →
VIVK

VIVK Premarket Squeeze: Third Crude-Oil PR in Eight Days Hits a Post-Split Float Under 600K Shares

Jul 29, 2026

Vivakor's third billion-dollar crude-marketing headline in eight days just hit a post-reverse-split float under 600K shares — the premarket squeeze is real, and so is the $100M equity facility sitting behind it.

Read →
LGHL

LGHL Round-Trips Again: Monday's 50% Spike Came With No News — Just a Six-Figure Float

Jul 27, 2026

LGHL gapped over 100% premarket Monday and has already given back a third of the open — with zero fresh news. The whole move is float mechanics: a six-figure ADS count after three reverse splits in 16 months, 15% short interest, and a market maker filing sales all week.

Read →
EDBL

EDBL More Than Doubles Pre-Market on Walmart Herb Deal — But the Real Story Is a Float You Could Fit in a Greenhouse

Jul 27, 2026

Edible Garden's Walmart Mid-Atlantic herb expansion lit the match, but a mid-six-figure float — the product of two reverse splits in six months — is why EDBL more than doubled before the open.

Read →
BNRG

BNRG: EIB Debt Waiver Lands on a Sub-3M Float — Mapping the Levels Into the July 29 Vote

Jul 24, 2026

Brenmiller Energy gapped up over 40% premarket on an EIB waiver deferring its loan payment ahead of a debt-reducing settlement — real news hitting a sub-3M float with a 7.2M-share resale shelf and a $1.30 warrant threshold hanging over the July 29 vote.

Read →
INLF

INLF Doubles Premarket on No News — a 3,200-to-1 Reverse Split Left Almost Nothing to Trade

Jul 22, 2026

INLF spiked past $7 premarket on zero news, then gave most of it back. The real story is a 3,200-to-1 cumulative reverse split that left almost no shares to trade — and insider exit filings hitting right before the halts.

Read →
LABT

LABT Rips 250% Premarket on a Sub-1M Float: Anatomy of a Squeeze

Jul 22, 2026

LABT gapped ~250% in premarket on Nu-3 resistance data, but a sub-million-share float and 30x-float volume are doing the real work. Here's the mechanics read and the levels.

Read →
KIDZ

KIDZ Runs Again on a $44.6M GPU Deal — Run One's Round Trip Is the Textbook for Run Two

Jul 21, 2026

KIDZ is up big premarket on a $44.6M GPU compute contract with Canopy Wave — a real deal with a real catch: the capex is non-cancellable and the funding machinery is a $100M equity line with 151M shares registered against a two-million-share float.

Read →
BIYA

BIYA Doubles Premarket: Anatomy of a Post-Reverse-Split Float Squeeze

Jul 20, 2026

No headline is driving BIYA's premarket double — a 1-for-10 reverse split shrank the share count to ~2.7M on July 13, and three sessions later the tape found the float. Here's how the squeeze works and where it breaks.

Read →
SDOT

SDOT Gaps Premarket After $350K Settlement Kills the Helena ELOC — and the Lawsuit With It

Jul 17, 2026

Sadot Group is running premarket after a July 16 8-K revealed a $350K settlement that dismisses the Helena lawsuit and terminates the equity line — pulling a dilution pipe off a sub-1M float.

Read →
SLND

SLND Rips Pre-Market as Winnipeg Consortium Lands C$815M Sewage Plant Contract

Jul 17, 2026

Southland Holdings gapped over 50% pre-market after an Aecon-led consortium — with Southland's subsidiary holding a third — won a C$815M Winnipeg sewage plant contract. Tight float plus real news; here's the bracket.

Read →
DXST

DXST Turns Its Float Over Ten Times Before the Open — and the Tape Is Already Below VWAP

Jul 16, 2026

DXST ripped premarket on no news, churning its tiny float roughly ten times before the open — but the tape is already back below VWAP, and the July 14 EGM put a 900M-share authorization on the table.

Read →
TGHL

TGHL Gaps Up on Signed EnChem Merger — But the Delisting Clock Is Still in the Deal

Jul 16, 2026

GrowHub signed its definitive merger agreement with Korean battery-materials maker EnChem, and the stock is gapping hard premarket. The catalyst is real — but it's confirmation of a May term sheet, and the deal can terminate if Nasdaq's pending delisting determination sticks.

Read →
JTAI

JTAI's $10-a-Share Headline Meets a $5 Tape: Handicapping Jet.AI's Reverse-Takeover Gap

Jul 15, 2026

Jet.AI's morning update pitched $10 per share in stock and cash from a $300M+ reverse takeover — the tape spiked to the low $7s and faded to $5. The gap is the market pricing a non-binding LOI with an unnamed counterparty.

Read →
VIVS

VIVS Runs Triple Digits Premarket as Eli Lilly Milestone Check Exceeds Its Entire Market Cap

Jul 15, 2026

VivoSim Labs ripped from 52-week lows on a $5M Eli Lilly milestone payment that exceeds its entire market cap — but the premarket tape already faded from the mid-$3s to below $2, and the ATM is armed.

Read →
NXTC

NXTC Quadruples Premarket as Avere Therapeutics Reverse Merger Lands With $320M Behind It

Jul 14, 2026

NextCure roughly quadrupled in Tuesday's premarket after announcing an all-stock merger with Avere Therapeutics — an ex-Akero team, an oral once-weekly IL-23 drug, and $320M in concurrent financing. The stub's value hinges on net cash at close.

Read →
SHPH

SHPH Rips Premarket on a Sub-600K Float — No News, Just Mechanics and a Dogecoin Overhang

Jul 14, 2026

SHPH is ripping premarket with zero news behind it — just a sub-600K float, a fresh 10-for-1 reverse split, and a Dogecoin merger whose convertible paper is multiples of the entire tradable supply.

Read →
QTTB

QTTB Rips Premarket on Positive Alopecia Data — The Tape, the Shelf, and the Levels That Matter

Jul 13, 2026

Q32 Bio's 36-week alopecia data hit clean and the sub-10M float repriced violently premarket — but a $300M shelf filed two weeks before the readout says supply may be next.

Read →
PLSM

PLSM Rips Premarket on Israel AI Sandbox Win — Right After 3.1M Resale Shares Went Effective

Jul 13, 2026

Pulsenmore spiked premarket on its selection to lead a $1M Israeli healthcare AI project — but a 3.1M-share resale registration went effective one trading day earlier, and the last spike round-tripped in under three weeks.

Read →
GMM

GMM Rips Premarket on a China Micro-Cap Frenzy — a 1.68M Float Doing All the Work

Jul 10, 2026

Global Mofy AI is the top premarket gapper with no company news behind it — a China small-cap frenzy hit a 1.68M post-split float, and Thursday's 100x volume spike at the 52-week low was the tell.

Read →
CCHH

CCHH Gaps on $50M Data Center Pivot — A Hotpot Chain With a 4M Float Meets Malaysia's Hottest Sector

Jul 7, 2026

A Malaysian hotpot chain announced a $50M data center infrastructure maintenance agreement at 8:15 AM ET, and its 4.1M-share float turned over several times before the open. Here's the bracket and what the press release didn't say.

Read →
TDTH

TDTH Premarket Surge: Founder's $8M Debt Swap and a Shareholder Vote Tomorrow Put the Recap Trade Front and Center

Jul 7, 2026

TDTH gapped into the mid-$3s premarket on Tuesday after Monday's announcement that its founder will swap $8M of debt for 901M restricted Class B shares — with the shareholder vote landing tomorrow and an ADS termination on July 16.

Read →
KIDZ

KIDZ Doubles on a Company-Announced Award — the Real Story Is 151M Shares of Paper Waiting Offstage

Jul 6, 2026

KIDZ doubled Monday morning on a self-announced award and the KIDZBot unveil — but the June 29 S-1 registers 151 million shares of forward supply under a Chardan equity line, against a float barely above a million.

Read →
AAPL

AAPL's Foldable-Fueled Breakout Runs Into a Margin Problem the Tape Is Ignoring

Jul 4, 2026

Apple ripped nearly 5% Thursday on reports of a 10-million-unit foldable iPhone order — but the same two weeks brought a margin-driven selloff, a Supreme Court showdown, and a valuation stretched well past its five-year norm.

Read →
AHMA

AHMA Wakes Up: Dubai Travel Stock Surges 15% But That's Nothing Like February's $39 High

May 7, 2026

AHMA jumps 15% with heavy volume, but traders need perspective — this Dubai travel stock peaked at $39.50 in February and we're still 95% below that high.

Read →
SOBR

SOBR Safe Stock: How a Failed Alcohol Monitoring Company Became a Green Energy Shell

May 7, 2026

SOBR Safe's 123% spike reveals the mechanics of a failing alcohol tech company becoming a Clean World Ventures green energy shell, with existing shareholders diluted to 2% ownership.

Read →
GLE

GLE Surges 71% on Satellite Partnership MOU — But Delisting Clock Still Ticking

May 7, 2026

Global Engine Group rockets on AI-satellite infrastructure deal with Angkasa-X, yet investors buying a company racing against an October 26 Nasdaq delisting deadline.

Read →
ERNA

ERNA Explodes 52% Pre-Market as "100% Survival" Data Meets Post-Split Reality

May 6, 2026

Ernexa drops breakthrough preclinical data showing complete tumor elimination, but traders need to understand the dilution mechanics and timing risks behind this biotech moonshot.

Read →
EVC

EVC Rockets 73% Pre-Market as ATS Revenue Surges 204% in Blowout Q1

May 6, 2026

EVC explodes 73% pre-market after reporting 114% revenue growth driven by 204% surge in advertising technology services, while positioning for massive political advertising cycle in 2026.

Read →
AHMA

AHMA Surges 62% Pre-Market After Massive Volume — Trader's Paradise or Classic Small-Cap Trap?

May 6, 2026

AHMA explodes 62% pre-market on 17x normal volume, but UAE tourism exposure and dual-class share structure create classic small-cap risk-reward setup.

Read →
GCTK

GCTK: Pre-Market Surge Follows Journal Publication as FDA Filing Approaches

May 6, 2026

GlucoTrack surges 37% pre-market as peer-reviewed diabetes monitor study publication builds momentum ahead of critical FDA filing expected within 4-8 weeks.

Read →
BLZE

BLZE: The Earnings Beat That Wall Street Missed - But Can the AI Story Scale?

May 5, 2026

Backblaze crushed Q1 earnings with a shocking $0.04 EPS versus -$0.11 expected, yet Wall Street yawned. The disconnect tells a story about small-cap cloud infrastructure that traders need to understand.

Read →
DGXX

DGXX: $1.1B Cerebras Deal Sparks 47% Pre-Market Surge

May 5, 2026

DGXX explodes 47% pre-market after announcing a $1.1B AI data center deal with Cerebras Systems, validating the miner-to-AI infrastructure pivot with institutional-grade revenue visibility.

Read →
SDOT

SDOT: The Compliance Filing That Triggered a 109% Dead Cat Bounce

May 5, 2026

SDOT exploded 109% on a simple compliance filing, but the real story is a 125x increase in authorized shares and guaranteed dilution ahead.

Read →
CLRB

CLRB Explodes 58% Pre-Market as $140M Nantahala Deal Powers Regulatory Path

May 5, 2026

Cellectar Biosciences erupts pre-market after announcing massive oversubscribed financing and compelling 12-month Waldenstrom macroglobulinemia data that strengthens FDA filing prospects.

Read →
RECT

RECT's Pre-Market Pop: How the $32.6M Bitcoin SEPA Works and What It Means

Apr 13, 2026

Rectitude Holdings surged 47% pre-market as traders digest the mechanics of its Bitcoin treasury strategy funded by a standby equity agreement with crypto veterans.

Read →
RCT

RCT Rockets 114% on Saudi Deal but Dilution Machine Keeps Grinding

Apr 13, 2026

RCT exploded 114% pre-market on a Saudi licensing deal, but the celebration masks a deeper story of chronic dilution and unsustainable cash burn that licensing agreements won't fix.

Read →
RMSG

RMSG: The Tape Tells a Different Story Than the Headlines

Apr 13, 2026

RMSG just doubled overnight on massive volume while everyone focuses on Nasdaq compliance issues. The tape suggests smart money sees opportunity in the distress.

Read →
AIXI

AIXI Explodes 51% Pre-Market on Apple Patent Play — But the Delisting Clock Is Still Ticking

Apr 10, 2026

AIXI rockets 51% pre-market as the Apple patent momentum trade reignites, but delisting risk, a wrecked balance sheet, and micro-cap mechanics make this one of the most dangerous tickers on the board.

Read →
RAYA

RAYA Surges 107% Pre-Market on $400K Private Placement — The Micro-Cap Dilution Machine Cranks Up Again

Apr 10, 2026

RAYA rockets over 100% pre-market after disclosing a $400K offshore private placement at $0.08 per share while running a $20M ATM facility — textbook small-cap volatility meets dilution mechanics.

Read →
CREG

CREG Up 39% Pre-Market: The Red Flags Behind Smart Powerr's Momentum

Apr 10, 2026

CREG surges on no news, but the filing history reveals a dilution machine with questionable business fundamentals — here's what the documents actually show.

Read →
GLMD

GLMD: Brain-Penetrating Aramchol News Drives 88% Premarket Surge

Apr 9, 2026

GLMD explodes 88% higher premarket after announcing breakthrough brain-penetrating formulation of Aramchol, potentially expanding from NASH treatment into massive CNS disease markets.

Read →
ONCO

ONCO Pops 38% Pre-Market as Realbotix AI Robot Delivery Narrative Fights Dilution Reality

Apr 9, 2026

ONCO jumps 38% pre-market after Realbotix delivered its first AI-equipped humanoid robot to Ericsson, but the real story is massive shareholder dilution from a pending acquisition that could give existing investors as little as 10% of the combined company.

Read →
QNCX

QNCX Pre-Market Surge: Distressed Biotech Rides Momentum Wave After Strategic Review

Apr 8, 2026

QNCX doubles in pre-market on no fresh news, riding biotech momentum despite failed Phase 3 trials and ongoing strategic review — a high-risk momentum play with thin float dynamics.

Read →
BBGI

BBGI Surges 70% Pre-Market as Debt Restructuring Meets Earnings Beat

Apr 8, 2026

Beasley Broadcast explodes higher on earnings day as debt restructuring progress and better-than-expected Q4 results trigger massive short squeeze.

Read →
OMEX

OMEX Odyssey Marine: $1B Merger Deal Powers 162% Pre-Market Surge

Apr 8, 2026

OMEX rockets 162% pre-market on a $1B merger deal with American Ocean Minerals, but the required 25-for-1 reverse stock split reveals the dilution reality behind the billion-dollar headlines.

Read →
IPST

IPST Erupts 61% Pre-Market: The Heritage Distillery Turned Blockchain IP Play That Nobody Saw Coming

Apr 7, 2026

Heritage Distilling's complete pivot to IP Strategy Holdings caught the market flat-footed, with the stock now up 61% pre-market as traders scramble to understand the Story Protocol validator play.

Read →
SILO

SILO Pharma Patent Win Drives 62% Pre-Market Surge But Dilution Risk Lurks

Apr 7, 2026

SILO explodes 62% on European PTSD patent approval, but its history of dilutive offerings and massive cash burn create a complex risk-reward setup for momentum traders.

Read →
HCAI

HCAI Surges 203% on Nasdaq Extension — A Final Act Before Delisting?

Apr 7, 2026

Huachen AI Parking explodes on news it got more time to fix its sub-dollar problem, but this looks like desperation buying on a dilution machine with no real catalyst.

Read →
CETX

CETX Spikes 125% Pre-Market on Navy SBIR Contract Win

Apr 7, 2026

Cemtrex subsidiary Invocon lands Phase I Navy SBIR contract for mine warfare technology, validating the company's aerospace pivot just months after completing its $7.06M acquisition.

Read →
FCUV

FCUV's 109% Pre-Market Surge: AI Hype Meets Small-Cap Reality Check

Apr 6, 2026

Focus Universal rockets 109% pre-market on AI software claims, but traders should watch the float and fundamentals before chasing.

Read →
MLEC

MLEC: The Reverse Split Arithmetic Everyone Missed

Apr 6, 2026

While traders chase the 24% pre-market pop, Moolec Science's real story lies buried in complex restructuring mechanics that Wall Street might have miscalculated.

Read →
PFSA

PFSA: Biotech Dilution Machine Hits the Jackpot with Mayo Clinic Partnership and $30M Acquisition Play

Apr 6, 2026

Profusa soars 130% pre-market on PanOmics acquisition and Mayo Clinic partnership, but extreme dilution risk and 377% short interest tell a different story.

Read →
TMDE

TMDE Surges 61% Pre-Market on Iran Crisis — But the IPO Math Tells a Different Story

Apr 2, 2026

TMD Energy rocketed in pre-market trading as Middle East tensions spike oil prices, but beneath the geopolitical pop lies a classic post-IPO dilution story with razor-thin margins and troubling cash flow.

Read →
BCG

BCG: Binah Capital Group's First Profitable Year Masks Real Dilution Concerns

Apr 1, 2026

While BCG surged 30% on earnings that showed its first full-year profit as a public company, the celebration might be premature given hidden dilution risks and leverage concerns.

Read →
CYCN

CYCN Stock Explodes 439% on $380M Korsana Merger - Reverse Takeover Transforms Penny Biotech

Apr 1, 2026

CYCN exploded 439% this morning on a $380M reverse merger with Korsana Biosciences, transforming a penny biotech shell into an institutional-backed Alzheimer's drug play.

Read →
ARTL

ARTL Stock Surges 163% as Clinical Expansion into $16.3B Glaucoma Market Demonstrates Platform Power

Mar 27, 2026

ARTL exploded 163% overnight as clinical expansion into the $16.3B glaucoma market demonstrates the power of a diversified cannabinoid platform targeting multiple billion-dollar therapeutic verticals.

Read →
EEIQ

EEIQ Stock Explodes 134% as Compliance Mechanics Play Out Perfectly

Mar 26, 2026

EEIQ delivered a textbook compliance squeeze, surging 134% on 140x normal volume as the company regained Nasdaq minimum bid requirements just days before their March 2 delisting deadline.

Read →
LNAI

LNAI Rockets 57% on $20M Brain-Delivery Deal as Traders Play Delisting Drama

Mar 26, 2026

LNAI explodes 57% on $20M blood-brain barrier acquisition deal as traders position around today's NASDAQ delisting hearing outcome.

Read →
RMSG

RMSG: 121% Spike Masks Serious Delisting Risk at Real Messenger

Mar 25, 2026

Real Messenger's massive Monday surge looks like classic penny stock manipulation as the company faces Nasdaq delisting after falling below $1 for 30 straight days.

Read →
NXTT

NXTT: The Anatomy of a Pump and Dump Disguised as a Bitcoin Play

Mar 25, 2026

Next Technology's spectacular collapse from $28 to $1.20 in three months reveals the brutal mechanics of dilution machines masquerading as bitcoin treasuries.

Read →
ITOC

ITOC Rockets 80% Pre-Market After $20M Private Placement at Big Discount

Mar 25, 2026

ITOC rockets 80% pre-market after announcing a $20M private placement at $0.20 per share, creating arbitrage dynamics and dilution risk for the beaten-down cancer treatment software play.

Read →
NUCL

NUCL Breaks Out 29% as Uranium Bulls Return — But Know the Dilution Risk

Mar 24, 2026

Eagle Nuclear explodes higher on sector momentum and permitting news, but small-cap uranium plays carry serious float expansion risks.

Read →
GOCO

GOCO: Dead Cat Bounce After Hitting All-Time Low - The Dilution Machine Still Running

Mar 24, 2026

GoHealth surged 22% Monday after touching $1.31 all-time lows in early March, but the rally masks deeper structural problems from massive dilution and deteriorating fundamentals.

Read →
RBNE

RBNE Rockets 87% on $3 Tender Offer: Buyback Signal or Value Trap?

Mar 24, 2026

Robin Energy explodes 87% on surprise $3 tender offer, creating potential arbitrage play but highlighting the risks of a serial dilution machine.

Read →
FEED

FEED Jumps 51% Pre-Market as ENvue Medical Expands Hospital Footprint, But Series H Conversion Overhang Looms

Mar 24, 2026

ENvue Medical surges on Detroit hospital deal expanding its feeding tube navigation platform to 39 hospitals, but Series H preferred shares create 800% dilution overhang.

Read →
PAVS

PAVS: The Dilution Machine Suddenly Stops — But Is Anyone Still Paying Attention?

Mar 24, 2026

PAVS jumped 93% after ending its share dilution program with AGP, but the mechanics suggest this is temporary relief rather than a fundamental turnaround.

Read →
PMAX

PMAX Explodes 29% on Boston Solar Deal — But Dilution Risk Remains Heavy

Mar 23, 2026

Powell Max caught fire on news of a $9M solar acquisition, but traders need to read between the lines on this micro-cap's cash-burning structure.

Read →
GMEX

GMEX Surges 35% on First Commercial Order — Understanding the Robotics Pivot

Mar 23, 2026

GMEX exploded 35% on its first commercial robotics order worth AU$4.2M — three times the company's market cap. Here's how the fitness-to-robotics transformation is playing out and what traders need to watch.

Read →
ZYBT

ZYBT Pops 19% But Dilution Hangover Remains From $14 High

Mar 23, 2026

ZYBT bounced hard off March 2nd's close but the Chinese vet vaccine maker still trades 94% below its April 2025 peak amid ongoing dilution concerns.

Read →
AHMA

AHMA: Travel Stock's 73% Surge Masks Corporate Governance Red Flags

Mar 23, 2026

AHMA's 73% surge on travel industry news masks serious governance restructuring and extreme valuations that suggest this momentum play carries significant risks.

Read →
UGRO

UGRO Explodes 74% in Pre-Market After Reverse-Split Squeeze Meets Flash Merger

Mar 23, 2026

UGRO ripped 74% to $3.79 in Sunday's pre-market session after a brutal 25:1 reverse split created massive mechanical pressure on what's now a minuscule 684K share float.

Read →
MGRX

MGRX: The $73 Million Hail Mary - Why This Lawsuit Play Doubled Overnight

Mar 23, 2026

MGRX popped 116% on a $73M lawsuit against its former tech partner, but the damages sought are 11x the company's market cap—classic small-cap narrative engineering.

Read →
AGRZ

AGRZ: Vertical Farm Play Catches Fertilizer Wave at Critical Technical Crossroads

Mar 20, 2026

Agroz bounced 153% last Thursday on the Strait of Hormuz crisis, then gave back 27% Friday. Now trading at key support with a Nasdaq compliance deadline looming.

Read →
ANNA

ANNA Surges 50% on Iran War Energy Crisis But Major Insider Sells Signal Caution

Mar 20, 2026

ANNA explodes 50% as Iran war drives energy crisis, but massive insider selling from controlling shareholders just before the rally raises serious red flags about sustainability.

Read →
AZTR

AZTR: Private Placement Lifeline or Dilution Trap?

Mar 20, 2026

AZTR rockets 92% on desperate biotech financing that could deliver either runway extension or massive dilution trap for retail traders.

Read →
WETO

WETO's Phantom Surge: What the 57% Pop on Corporate Rebrand News Doesn't Tell You

Mar 19, 2026

Wetour Robotics' 57% surge Wednesday masks deeper questions about dilution risk and a pivot from struggling travel tech to unproven AI infrastructure.

Read →
SER

SER Private Placement Mechanics: How Serina's $30M Raise Shows the New Biotech Financing Playbook

Mar 19, 2026

Serina Therapeutics surged 76% on a $30M private placement deal, but the real story is in the warrant mechanics and potential $63M dilution structure.

Read →
LNKS

LNKS Pops 24% Pre-Market on No News After Massive Dilution Filing

Mar 19, 2026

Linkers Industries surges pre-market despite filing to dump up to 405 million shares into the market just days ago, raising questions about what traders aren't seeing.

Read →
CHNR

CHNR Explodes 71% Pre-Market on AI Pivot, But This Mining Stock's Real Test Lies Ahead

Mar 19, 2026

China Natural Resources rockets on HooRii Technology acquisition announcement, but traders should watch the $37-40 million dilution event closely — the Physical AI story might be secondary to the balance sheet math.

Read →
EVTV

EVTV: The Electric Vehicle Stock That Broke Bad and Went Full AI — Tape Read

Mar 18, 2026

EVTV's 46% rip on 8.3M volume tells the story of a desperation pivot gone right, but dilution demons still lurk in the shadows.

Read →
ARTL

ARTL Pops 33% on Glaucoma Study Deal, But Don't Ignore the Warning Signs

Mar 18, 2026

ARTL exploded 33% on glaucoma study news with 72x float volume, but the cash burn and dilution risks make this more squeeze than substance.

Read →
VNRX

VNRX Pops 39% on "World-First" Liquid Biopsy Breakthrough Amid Delisting Risks

Mar 18, 2026

VNRX explodes 39% on breakthrough liquid biopsy claims, but massive volume and delisting pressures create a complex risk-reward setup.

Read →
LBGJ

LBGJ: The Anatomy of a 138% Pre-Market Pump — And Why It's Already Unwinding

Mar 18, 2026

LBGJ rockets 138% in pre-market but immediately begins fading from highs, exposing the mechanical nature of the move and underlying dilution risks.

Read →
AIM

AIM ImmunoTech (AIM) Explodes 110% Pre-Market After Japan Patent Win Triggers Fresh Catalyst

Mar 18, 2026

AIM explodes 110% pre-market after securing final Japanese patent approval for Ampligen cancer combination therapy, but dilution risks loom from recent rights offering.

Read →
BIAF

BIAF's Wild March Ride: The Rise, the Hype, and the Reality Check

Mar 17, 2026

bioAffinity Technologies exploded 122% on March 13 earnings, then gave back gains as investors parsed the dilution-heavy reality behind the revenue surge.

Read →
UCAR

UCAR Explodes 67% Pre-Market: Thailand Truck Deal Sparks Skepticism and Opportunity

Mar 17, 2026

UCAR explodes 67% pre-market on Thailand battery-truck news, but the skeptic's math reveals dilution risks that bulls are ignoring in this micro-cap momentum play.

Read →
LNAI

LNAI: When The Float Breaks — Anatomy of a 160% Pre-Market Spike Gone Wrong

Mar 17, 2026

LNAI exploded 160% pre-market Monday on classic squeeze mechanics, but this dying biotech's final spike before potential delisting represents everything dangerous about small-cap trading.

Read →
WNW

WNW Stock Rockets 570% on AI Initiative, But Dilution Risk Looms Large

Mar 16, 2026

Meiwu Technology's shares exploded from $1.80 to $13.52 after announcing an AI-powered skincare R&D program, but recent dilution and pending shelf offerings cloud the momentum play.

Read →
ABCD

ABCD Pre-Market Momentum: The Filing Nobody's Talking About

Mar 14, 2026

ABCD ripped 18% pre-market on volume that doesn't match anything in the last 30 days. No PR. No earnings. So what moved it?

Read →
EFGH

EFGH Postmortem: How a 424B5 Filing Turned a 40% Runner Into a Trap

Mar 13, 2026

EFGH ran 40% in the first hour yesterday. By close, it was red. Here's what the filing told you at 7 AM that most people didn't read until it was too late.

Read →
IJKL

IJKL: FDA Catalyst, Tight Float, and a Setup That Actually Looks Interesting

Mar 12, 2026

Most small-cap FDA plays are lottery tickets. IJKL might actually have the structure to hold a move — if you understand the float dynamics.

Read →